On April 18, 2001, SIGA Technologies, Inc. (Nasdaq: SIGA) elected Kramer Levin partner Thomas Constance to its Board of Directors. SIGA intends to increase their potential in the worldwide market by focusing on technologies for the treatment and prevention of bacterial infections.